Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer [PDF]
Cancer Management and Research, 2020 Zichen Bian,1,* Jialin Meng,1,* Qingsong Niu,1 Xiaoyan Jin,2 Jinian Wang,3 Xingliang Feng,1 Hong Che,4 Jun Zhou,1 Li Zhang,1 Meng Zhang,1,5 Chaozhao Liang1 1Department of Urology, The First Affiliated Hospital of Anhui Medical University; Anhui Province ...
Bian Z +10 more
doaj +3 more sources
The progress of prothrombin time measurement
Hematology Reports, 2009 Warfarin is the most widely used medicine for oral anticoagulant therapy (OAT). It inhibits the synthesis of coagulation factors II, VII, IX, and X in the liver and results in the production of inactive or partially active versions of these factors ...
Juha Eero Horsti
doaj +5 more sources
Prolonged prothrombin time as an early prognostic indicator of severe acute respiratory distress syndrome in patients with COVID-19 related pneumonia. [PDF]
Curr Med Res Opin, 2021 Background Clinical observations demonstrated that COVID-19 related pneumonia is often accompanied by hematological and coagulation abnormalities including lymphopenia, thrombocytopenia, and prolonged prothrombin time.
Baranovskii DS +6 more
europepmc +2 more sources
Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article [PDF]
Thrombosis Journal, 2021 The antithrombotic effect of vitamin K antagonists (VKA) depends on controlled lowering of the activity of factors (F) II and X whereas reductions in FVII and FIX play little role. PT-INR based monitoring, however, is highly influenced by FVII, which has
Pall T. Onundarson +3 more
doaj +2 more sources
Prolonged prothrombin time at admission predicts poor clinical outcome in COVID-19 patients. [PDF]
World J Clin Cases, 2020 BACKGROUND The prognostic value of coagulation disorder in coronavirus disease 2019 (COVID-19) patients should be demonstrated. AIM To investigate the abnormalities of coagulation parameters in the patients with COVID-19 and their prognostic values ...
Wang L, He WB, Yu XM, Hu DL, Jiang H.
europepmc +2 more sources
D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis. [PDF]
Biomed Res Int, 2020 Objective To investigate the value of coagulation indicators D-dimer (DD), prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), and fibrinogen (Fg) in predicting the severity and prognosis of COVID-19.
Long H +9 more
europepmc +2 more sources
Diagnostic performances of D-dimer, prothrombin time, and red blood cell distribution width for coronary artery lesion in children with acute stage Kawasaki disease [PDF]
Frontiers in Pediatrics, 2023 AimTo evaluate the performances of D-dimer, prothrombin time (PT), and red blood cell distribution width (RDW) for the diagnosis of coronary artery lesion (CAL) in acute stage Kawasaki disease (KD).MethodsBetween January 2018 and January 2021, a total of
Qi-Gai Yin +5 more
doaj +2 more sources
The varied sensitivity of partial thromboplastin and prothrombin time reagents in the demonstration of the lupus-like anticoagulant. [PDF]
Scandinavian Journal of Haematology, 2009 An acquired inhibitor of blood coagulation, similar to that described in patients with Systemic Lupus Erythematosus (SLE), was detected during routine coagulation screening in 10 patients who did not meet the criteria for a diagnosis of SLE.
P. Mannucci +3 more
semanticscholar +2 more sources
Should we Test the Prothrombin Time in Anticoagulated Epistaxis Patients?
Allergy & Rhinology, 2013 Epistaxis is one of the most frequent emergencies in rhinology. Patients using anticoagulative medication are at increased risk for epistaxis. We evaluated the prothrombin time and the international normalized ratio (INR) in anticoagulated epistaxis ...
Michael B. Soyka M.D. +1 more
doaj +2 more sources
Paediatrica Indonesiana, 2009 Background Vitamin K deficiency can cause bleeding disorders in healthy breastfed infants. The efficacy of newborn intramuscular vitamin K prophylaxis for the prevention of this bleeding problem has been well established, but this is an invasive ...
Nancy Ervani +4 more
doaj +3 more sources